AAAAAA

   
Results: 1-14 |
Results: 14
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase
Authors: Vonderheide, RH Anderson, KS Hahn, WC Butler, MO Schultze, JL Nadler, LM
Citation: Rh. Vonderheide et al., Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase, CLIN CANC R, 7(11), 2001, pp. 3343-3348
CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity
Authors: Vonderheide, RH Butler, MO Liu, JF Battle, TE Hirano, N Gribben, JG Frank, DA Schultze, JL Nadler, LM
Citation: Rh. Vonderheide et al., CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity, INT J ONCOL, 19(4), 2001, pp. 791-798
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens
Authors: Schultze, JL Maecker, B von Bergwelt-Baildon, MS Anderson, KS Vongerheide, RH
Citation: Jl. Schultze et al., Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens, VOX SANGUIN, 80(2), 2001, pp. 81-89
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals
Authors: Vonderheide, RH Schultze, JL Anderson, KS Maecker, B Butler, MO Xia, ZN Kuroda, MJ von Bergwelt-Baildon, MS Bedor, MM Hoar, KM Schnipper, DR Brooks, MW Letvin, NL Stephans, KF Wucherpfennig, KW Hahn, WC Nadler, LM
Citation: Rh. Vonderheide et al., Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals, CANCER RES, 61(23), 2001, pp. 8366-8370
Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A0201 restricted epitopes from the human epithelial cell adhesion molecule
Authors: Trojan, A Witzens, M Schultze, JL Vonderheide, RH Harig, S Krackhardt, AM Stahel, RA Gribben, JG
Citation: A. Trojan et al., Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A0201 restricted epitopes from the human epithelial cell adhesion molecule, CANCER RES, 61(12), 2001, pp. 4761-4765
A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2
Authors: Schultze, JL Anderson, KC Gilleece, MH Gribben, JG Nadler, LM
Citation: Jl. Schultze et al., A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2, BR J HAEM, 113(2), 2001, pp. 455-460
Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies
Authors: Trojan, A Schultze, JL Witzens, M Vonderheide, RH Ladetto, M Donovan, JW Gribben, JG
Citation: A. Trojan et al., Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies, NAT MED, 6(6), 2000, pp. 667-672
Molecular immunological modulation of target cells to enhance the GVL effect
Authors: Schultze, JL Gribben, JG
Citation: Jl. Schultze et Jg. Gribben, Molecular immunological modulation of target cells to enhance the GVL effect, BAS CLIN ON, 22, 2000, pp. 315-340
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
Authors: Vonderheide, RH Hahn, WC Schultze, JL Nadler, LM
Citation: Rh. Vonderheide et al., The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes, IMMUNITY, 10(6), 1999, pp. 673-679
Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?
Authors: Schultze, JL
Citation: Jl. Schultze, Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?, LEUK LYMPH, 32(3-4), 1999, pp. 223
T cell mediated immunotherapy for B cell lymphoma
Authors: Schultze, JL Nadler, LM
Citation: Jl. Schultze et Lm. Nadler, T cell mediated immunotherapy for B cell lymphoma, J MOL MED-J, 77(3), 1999, pp. 322-331
Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia
Authors: Schultze, JL Donovan, JW Gribben, JG
Citation: Jl. Schultze et al., Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia, J MOL MED-J, 77(2), 1999, pp. 259-265
Presentation of tumor antigens
Authors: Hart, DNJ Schultze, JL Stewart, AK
Citation: Dnj. Hart et al., Presentation of tumor antigens, SEM HEMATOL, 36(1), 1999, pp. 21-25
Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: Role of B cells in the maintenance of T cell responses
Authors: Schultze, JL Michalak, S Lowne, J Wong, A Gilleece, MH Gribben, JG Nadler, LM
Citation: Jl. Schultze et al., Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: Role of B cells in the maintenance of T cell responses, J EXP MED, 189(1), 1999, pp. 1-11
Risultati: 1-14 |